MSc of Biology, Sun Yat-Sen University, Focuses on gene, cell therapy, high-end medical device research and investment, many years of VC/PE investment experience, with > 15 successful investment cases, including 5 IPO projects

Pharmacy Doctor, Fudan University,

Research and investment in the field of anti-tumor drugs,

Experiences in consulting and healthcare investment,

Overseas mergers and acquisitions & innovative drug investment

Postdoctoral from Stanford University, former head of competitive intelligence and strategy in Novartis, Over 20 years of pharmaceutical industry research experience

M.D., MSc of health economics from Johns Hopkins University,

Investment in innovative drugs from the perspective of clinical needs, Work experiences in WHO headquarters and global leading healthcare information, R&D service enterprise

Doctor from Cambridge University and Jilin University,

Specialized in research and investment of innovative drugs

Member of Guangdong pharmacological society and Anti-tumor Drug Professional Committee